James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,120 shares at $32.59 ($134K) on 2017-11-01, disclosed to the SEC on 2017-11-08.
Open-market sale of $134k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 2,410 | $78K | 58.5% |
| 2 | $32.59 | 1,710 | $56K | 41.5% |
| Total | $32.58 avg | 4,120 | $134K | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $311K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $273K | — | Filing → |